>
DOJ Seeks $61M in Iranian Oil Proceeds Laundered Through Binance Accounts
9 Terrifying Truths About Long-Term Economic Crises
AI Is Creating "Doom Loops" All Over the Economy
US Households Pay 62% More For Water Than They Did A Decade Ago
SHOCK CASE REPORT: Advanced Alzheimer's Patient Regains Speech, Memory, Mobility...
Most artificial limbs rely on silicone or plastic to mimic human hands.
Flying cell tower beams phone signal to Japan from 10 miles up
Chinese Commercial Reactor Achieves Nuclear Fusion with Clean Hydrogen-Boron Fuel
Med Beds Just Took a MASSIVE Step Forward, Healing People in Days!
Palmer Luckey: Autonomous Weapons Are Ancient and Why Anduril Won't Build Humanoids | EP #295
A laser just photographed objects through six feet of concrete
Elon Musk's Next-Gen Motor Destroy Entire EV Industry
China's disputed satellite refueling heralds new space war era
BYD Will Put Solid-State Batteries In An EV Next Year: Executive

3 patients experienced complete remission after regularly taking fenbendazole.
But the cancer industry seems to hate it because it only costs about $11 per week.
Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects.
The case series highlights the remarkable stories of three cancer patients who achieved miraculous recoveries with fenbendazole after exhausting all conventional therapies.
After analyzing these cases, the abstract concluded, "FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies."
Adding to the growing evidence in support of fendendazole's use case against cancer, an Oklahoma man credited his miraculous cancer recovery to the pet med after overcoming terminal small cell lung cancer, defying a less than 1% survival rate and leaving doctors baffled.
This story is truly remarkable. Watch.